Tuesday, August 27, 2019 7:06:50 AM
RecycLiCoTM Pilot Plant Prepares for Stage 5 Testing to Recover Lithium Carbonate and Recycle Process Reagents and Water
SURREY, BC / ACCESSWIRE / August 27, 2019 / American Manganese Inc. (AMY.V)(AMYZF)(2AM.F) (“AMY” or the “Company”), is pleased to announce analytical results from the Company’s independent contract lab, Kemetco Research, an integrated science, technology and innovation company.
Using the Company’s patented RecycLiCoTM process, Kemetco attained 99.94% purity from the recovered NCA cathode material. The material was tested in stages 3 and 4 of the RecycLiCoTM pilot plant project.
Following the NCA cathode precursor purity results and previously achieved 99.93% purity from NMC cathode material, the Company is preparing to enter the final stage (stage 5) of the RecycLiCoTM pilot plant project for the recovery of battery-grade lithium carbonate and the recycling of process reagents and water.
“Kemetco’s expertise in development of hydrometallurgical processes has enabled them to meet their goals and the Company’s expectations during all stages of the pilot plant project. We are excited to close the loop on our patented process as the final stage of the project approaches,” said Larry Reaugh, President and CEO of American Manganese.
About Kemetco Research Inc.
Kemetco Research is a private sector integrated science, technology and innovation company. Their Contract Sciences operation provides laboratory analysis and testing, field work, bench scale studies, pilot plant investigations, consulting services, applied research and development for both industry and government. Their clients range from start-up companies developing new technologies through to large multinational corporations with proven processes.
Kemetco provides scientific expertise in the fields of Specialty Analytical Chemistry, Chemical Process and Extractive Metallurgy. Because Kemetco carries out research in many different fields, it can offer a broader range of backgrounds and expertise than most laboratories.
" I can't complain , but sometimes I still do . "
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM